| -1.29 / -0.72%|
The 27 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 188.82, with a high estimate of 244.55 and a low estimate of 144.85. The median estimate represents a +5.89% increase from the last price of 178.32.
The current consensus among 29 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.